Dosimetric comparison between modulated arc therapy and static intensity modulated radiotherapy in thoracic esophageal cancer: a single institutional experience

被引:13
作者
Choi, Kyu Hye [1 ]
Kim, Jina [1 ]
Lee, Sea-Won [1 ]
Kang, Young-nam [1 ]
Jang, HongSeok [1 ]
机构
[1] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiat Oncol, 222 Banpo Daero, Seoul 06591, South Korea
关键词
Esophagus cancer; Intensity-modulated radiotherapy; Modulated arc (mARC) technique; Dosimetric comparison;
D O I
10.3857/roj.2017.00241
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The objective of this study was to compare dosimetric characteristics of three-dimensional conforms I radiotherapy (3D-CRT) and two types of intensity-modulated radiotherapy (IMRT) which are step-and-shoot intensity modulated radiotherapy (s-IMRT) and modulated arc therapy (mARC) for thoracic esophageal cancer and analyze whether IMRT could reduce organ-at-risk (OAR) dose. Materials and Methods: We performed 3D-CRT, s-IMRT, and mARC planning for ten patients with thoracic esophageal cancer. The dose-volume histogram for each plan was extracted and the mean dose and clinically significant parameters were analyzed Results: Analysis of target coverage showed that the conformity index (CI) and conformation number (CN) in mARC were superior to the other two plans (CI, p =0.050; CN, p= 0,042), For the comparison of OAR, lung V5 was lowest in s-IMRT, followed by 3D-CRT, and mARC (p = 0.033), s-IMRT and mARC had lower values than 3D-CRT for heart V-30 (p = 0.039), V-40(p = 0.040), and V-50 (p = 0.032). Conclusion: Effective conservation of the lung and heart in thoracic esophageal cancer could be expected when using s-IMRT The mARC was lower in lung V-10, V-20, and V(30)than in 3D-CRT, but could not be proven superior in lung V-5 In conclusion, low-dose exposure to the lung and heart were expected to be lower in s-IMRT, reducing complications such as radiation pneumonitis or heart-related toxicities.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 16 条
[1]   Esophageal and Esophagogastric Junction Cancers, Version 1.2015 [J].
Ajani, Jaffer A. ;
D'Amico, Thomas A. ;
Almhanna, Khaldoun ;
Bentrem, David J. ;
Besh, Stephen ;
Chao, Joseph ;
Das, Prajnan ;
Denlinger, Crystal ;
Fanta, Paul ;
Fuchs, Charles S. ;
Gerdes, Hans ;
Glasgow, Robert E. ;
Hayman, James A. ;
Hochwald, Steven ;
Hofstetter, Wayne L. ;
Ilson, David H. ;
Jaroszewski, Dawn ;
Jasperson, Kory ;
Keswani, Rajesh N. ;
Kleinberg, Lawrence R. ;
Korn, W. Michael ;
Leong, Stephen ;
Lockhart, A. Craig ;
Mulcahy, Mary F. ;
Orringer, Mark B. ;
Posey, James A. ;
Poultsides, George A. ;
Sasson, Aaron R. ;
Scott, Walter J. ;
Strong, Vivian E. ;
Varghese, Thomas K., Jr. ;
Washington, Mary Kay ;
Willett, Christopher G. ;
Wright, Cameron D. ;
Zelman, Debra ;
McMillian, Nicole ;
Sundar, Hema .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (02) :194-227
[2]   Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer [J].
Darby, Sarah C. ;
Ewertz, Marianne ;
McGale, Paul ;
Bennet, Anna M. ;
Blom-Goldman, Ulla ;
Bronnum, Dorthe ;
Correa, Candace ;
Cutter, David ;
Gagliardi, Giovanna ;
Gigante, Bruna ;
Jensen, Maj-Britt ;
Nisbet, Andrew ;
Peto, Richard ;
Rahimi, Kazem ;
Taylor, Carolyn ;
Hall, Per .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (11) :987-998
[3]   Commissioning and first clinical application of mARC treatment [J].
Dzierma, Yvonne ;
Nuesken, Frank G. ;
Kremp, Stephanie ;
Palm, Jan ;
Licht, Norbert P. ;
Ruebe, Christian .
STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (11) :1046-1052
[4]   TOLERANCE OF NORMAL TISSUE TO THERAPEUTIC IRRADIATION [J].
EMAMI, B ;
LYMAN, J ;
BROWN, A ;
COIA, L ;
GOITEIN, M ;
MUNZENRIDER, JE ;
SHANK, B ;
SOLIN, LJ ;
WESSON, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :109-122
[5]  
Emami B., 2013, REP RADIOTHER ONCOL, V1, P35
[6]   Conformity index:: A review [J].
Feuvret, L ;
Noël, G ;
Mazeron, JJ ;
Bey, P .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (02) :333-342
[7]   Dosimetric comparison between step-shoot intensity-modulated radiotherapy and volumetric-modulated arc therapy for upper thoracic and cervical esophageal carcinoma [J].
Gao, Min ;
Li, Qilin ;
Ning, Zhonghua ;
Gu, Wendong ;
Huang, Jin ;
Mu, Jinming ;
Pei, Honglei .
MEDICAL DOSIMETRY, 2016, 41 (02) :131-135
[8]   State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83) [J].
Gregoire, V. ;
Mackie, T. R. .
CANCER RADIOTHERAPIE, 2011, 15 (6-7) :555-559
[9]   Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients [J].
Kwa, SLS ;
Lebesque, JV ;
Theuws, JCM ;
Marks, LB ;
Munley, MT ;
Bentel, G ;
Oetzel, D ;
Spahn, U ;
Ten Haken, RK ;
Drzymala, RE ;
Purdy, JA ;
Lichter, AS ;
Martel, MK ;
TEN Haken, RK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (01) :1-9
[10]   Evaluation of the Clinical Usefulness of Modulated Arc Treatment [J].
Lee, Young Kyu ;
Jang, Hong Seok ;
Kim, Yeon Sil ;
Choi, Byung Ock ;
Kang, Young-Nam ;
Nam, Sang Hee ;
Park, Hyeong Wook ;
Kim, Shin Wook ;
Shin, Hun Joo ;
Lee, Jae Choon ;
Kim, Ji Na ;
Park, Sung Kwang ;
Kim, Jin Young .
JOURNAL OF THE KOREAN PHYSICAL SOCIETY, 2015, 67 (01) :232-236